Nantahala Capital Management, LLC Y M Abs Therapeutics, Inc. Transaction History
Nantahala Capital Management, LLC
- $2.29 Billion
- Q2 2025
A detailed history of Nantahala Capital Management, LLC transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Nantahala Capital Management, LLC holds 351,878 shares of YMAB stock, worth $2.99 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
351,878Holding current value
$2.99 Million% of portfolio
0.07%Shares
1 transactions
Others Institutions Holding YMAB
# of Institutions
97Shares Held
26MCall Options Held
24KPut Options Held
0-
Paradigm Biocapital Advisors LP New York, NY4.24MShares$36.1 Million0.89% of portfolio
-
Acorn Capital Advisors, LLC New York, NY3.42MShares$29.1 Million10.09% of portfolio
-
Black Rock Inc. New York, NY2.94MShares$25 Million0.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.19MShares$18.7 Million0.67% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.94MShares$16.5 Million0.0% of portfolio
About Y-mAbs Therapeutics, Inc.
- Ticker YMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,719,500
- Market Cap $372M
- Description
- Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...